Neuroendoscopic resection of a collision tumor involving null-cell adenoma and Adamantinomatous craniopharyngioma
Rare collision tumor found in patient with pituitary symptoms
This case report describes the surgical management of a 64-year-old female with a complex collision tumor. The authors highlight the diagnos…
A 64-year-old woman's complex symptoms led to the discovery of a rare dual tumor that was impossible to see on scans.
Early recognition of femoral metastasis in HNSCC is essential to facilitate timely palliative intervention
New data reveals management of head and neck cancer spread
This systematic review characterizes clinical features and management outcomes for patients with head and neck squamous cell carcinoma (HNSC…
Identifying how head and neck cancer spreads to the femur can help doctors provide better care and improve quality of life for patients.
FDA Approves Kisqali Femara Co-pack (ribociclib/letrozole) for HR+/HER2- Early and Advanced Breast Cancer
FDA approves Kisqali Femara Co-pack for two types of breast cancer.
The FDA approved Kisqali Femara Co-pack (ribociclib/letrozole) for adjuvant treatment of HR+/HER2- stage II/III early breast cancer at high …
The FDA approved Kisqali Femara Co-pack, a combination of two drugs in one package, for certain adults with HR-positive, HER2-negative breas…
FDA Approves Kisqali (ribociclib) for Adjuvant Treatment of Early Breast Cancer
FDA approves Kisqali to treat early breast cancer at high risk of recurrence.
FDA approved Kisqali (ribociclib) in combination with an aromatase inhibitor for adjuvant treatment of adults with HR-positive, HER2-negativ…
The FDA approved Kisqali (ribociclib) for early breast cancer in patients with HR-positive, HER2-negative stage II or III disease at high ri…
CT-based deep learning models show high accuracy predicting EGFR mutation status in lung adenocarcinoma
Machine learning models help predict lung cancer mutations from scans
This meta-analysis of 6,628 Chinese patients with lung adenocarcinoma found that machine learning-based radiomics models provide a noninvasi…
New analysis shows that deep learning models can accurately identify specific lung cancer mutations using standard CT scans.
SYHX2011 improves objective response rate to 35.8% compared to 25.8% for PAB in breast cancer
Trial shows SYHX2011 improves response rates for breast cancer
This Phase III randomized controlled trial of 459 patients with unresectable locally advanced or metastatic breast cancer found that SYHX201…
A new form of paclitaxel showed higher response rates and fewer skin rashes for patients with advanced or metastatic breast cancer.
Tai Chi Chih, cognitive behavioral therapy, and massage therapy reduce cancer-related fatigue in breast cancer
Tai Chi, therapy, massage ease breast cancer fatigue
This systematic review and network meta-analysis of 2811 participants evaluated non-pharmacological interventions for cancer-related fatigue…
A new analysis finds Tai Chi Chih, cognitive behavioral therapy, and massage therapy significantly reduce cancer-related fatigue in breast c…
EGFR inhibitors show reproducible activity and manageable toxicity in locally advanced or metastatic anal squamous cell carcinoma
EGFR Inhibitors Show Activity in Advanced Anal Squamous Cell Carcinoma
This meta-analysis of 404 patients evaluated EGFR inhibitors (cetuximab and panitumumab) for anal squamous cell carcinoma. The analysis foun…
New analysis shows that EGFR inhibitors like cetuximab and panitumumab may improve response rates for patients with advanced anal squamous c…
KYR intervention is non-inferior to conventional genetic counseling in breast cancer risk knowledge
Online genetic counseling works as well as in-person for high-risk women
This randomized trial of 866 women at elevated risk for breast cancer found the KYR intervention was non-inferior to conventional genetic co…
A new trial shows that online genetic counseling is just as effective as traditional in-person sessions for women at elevated breast cancer …
Higher log GDP per capita is associated with higher Comprehensive Score for Financial Toxicity
Wealthier countries see higher costs for patients with cancer
This meta-analysis of 83,623 patients across 75 studies found a pooled mean COST score of 21.2 (95% CI: 19.1-23.3). The analysis identified …
New data shows that while wealthier nations have more resources, their cancer patients often face higher financial toxicity and personal cos…
Meta Analysis Evaluates Hypokalemia Risks Associated with Androgen Receptor Axis Targeted Therapies
New Analysis Shows Risk of Low Potassium with Prostate Cancer Drugs
A meta-analysis of 9,298 patients reveals that abiraterone and combination therapies significantly increase hypokalemia risk in advanced pro…
Certain prostate cancer treatments, especially abiraterone and combination therapies, are linked to a significantly higher risk of low potas…
Rural residence and poor knowledge increase odds of delayed health-seeking behavior for cancer patients
Over half of cancer patients delay seeking medical care
This meta-analysis of observational data from Ethiopia identifies a 54% prevalence of delayed health-seeking behavior among cancer patients.…
More than half of cancer patients in Ethiopia delay seeking treatment due to factors like rural living and lack of awareness.